Noninvasive cardiovascular risk screening tools are crucial in assessing the risk of cardiovascular disease (CVD) in men, offering vital insights without invasive procedures. Key tools include electrocardiogram (ECG) for detecting heart rhythm abnormalities and myocardial infarctions; echocardiogram for evaluating heart structure and function; carotid ultrasound for identifying carotid artery stenosis and atherosclerosis; coronary artery calcium (CAC) scoring for quantifying atherosclerotic plaque; ankle-brachial index (ABI) for detecting peripheral arterial disease (PAD); pulse wave velocity (PWV) for measuring arterial stiffness; endothelial function testing for assessing endothelial health; cardiorespiratory fitness testing (VO2 Max) for evaluating cardiovascular fitness; and heart rate variability (HRV) analysis for monitoring autonomic function. These tools enable early detection, risk stratification, and effective management of cardiovascular risk factors. By providing comprehensive assessments of heart health and vascular function, they allow healthcare professionals to implement targeted preventive strategies, improving patient outcomes and quality of life.